Shares of Hims & Hers Health Inc. ($HIMS) experienced a sharp decline on June 23, 2025, dropping approximately 32% from recent levels to around $40. The stock reached an intraday low near $44.17, approaching technical support zones between $44 at the 21-week exponential moving average and $46 at the 1.272 Fibonacci retracement level, which some investors identified as potential buying opportunities. Market participants noted the volatility and some recommended selling put options to capitalize on the price movement. Despite the downturn, some investors maintained positions or added shares, citing long-term potential and viewing the dip as a buying opportunity. Others liquidated holdings, with one investor reporting a sale at $46 and realizing a return of roughly 3600 basis points since November 2023. The decline followed an earlier warning when the stock traded near $67. Leveraged ETFs tied to HIMS, such as the 2x leveraged $HIMZ, were also noted in the context of the price drop. Overall, the market reaction reflected a mix of cautious optimism and risk management amid the significant price adjustment.